Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO) Article

Sands, Jacob M, Mandrekar, Sumithra J, Kozono, David et al. (2021). Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO) . 13(9), 727-734. 10.2217/imt-2021-0019

Open Access

cited authors

  • Sands, Jacob M; Mandrekar, Sumithra J; Kozono, David; Oxnard, Geoffrey R; Hillman, Shauna L; Wigle, Dennis A; Govindan, Ramaswamy; Carlisle, Jennifer; Gray, Jhanelle; Salama, Joseph K; Raez, Luis; Ganti, Apar; Foster, Nathan; Malik, Shakun; Bradley, Jeffrey; Kelly, Karen; Ramalingam, Suresh S; Stinchcombe, Thomas E

sustainable development goals

authors

publication date

  • June 1, 2021

keywords

  • CHEMOTHERAPY
  • Immunology
  • Life Sciences & Biomedicine
  • MULTICENTER
  • NSCLC
  • OPEN-LABEL
  • PEMBROLIZUMAB
  • Science & Technology
  • adjuvant chemotherapy
  • lung adenocarcinoma
  • lung squamous cell carcinoma
  • pembrolizumab

Digital Object Identifier (DOI)

publisher

  • FUTURE MEDICINE LTD

start page

  • 727

end page

  • 734

volume

  • 13

issue

  • 9